- Datum18.06.2025
- UhrzeitLäuft gerade
- Veranstalter
XTB
Altan Cantürk
Moderator
Collegium Pharmaceutical Inc. Aktie
Verkaufen
Kaufen
Collegium Pharmaceutical Inc. Chart
Collegium Pharmaceutical Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-0,91 %
Intraday
-0,84 %
1 Woche
-2,61 %
1 Monat
2,76 %
Seit Jahresbeginn
-8,43 %
1 Jahr
85,98 %
3 Jahre
63,10 %
5 Jahre
51,99 %
10 Jahre
Passender Service zu Collegium Pharmaceutical Inc.
Webinar zu Collegium Pharmaceutical Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)23,230-42,287
- Jahrestief / Hoch ($)23,230-34,065
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Collegium Pharmaceutical Inc.
Keine Dividenden verfügbar
Termine von Collegium Pharmaceutical Inc.
Keine aktuellen Termine
Beschreibung
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
